Viking Therapeutics, Inc. (VKTX) short interest & options flow
NASDAQViking Therapeutics heads into its Q3 earnings print today with a stock down 30% over the past month, shorts sitting at 22.6% of the float, and options traders still leaning toward calls rather than puts. The short position is substantial but has been edging lower this week. Short interest fell from roughly 26.2 million shares on October 21 to 25.5 million by October 27, a 2%…
VKTX cost to borrow surges 116% in one week to 0.99%, highest level since late August as short availability tightens.
- Market cap
- $3.42B
- Next earnings
- 3 Feb 2027
Key data as of 8 Nov 2026
VKTX news and analysis
RSSNo long-form analysis yet for VKTX. Pulse alerts and the live data picture are available on ORTEX.
Open VKTX on ORTEX →Want the live picture for VKTX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VKTX — free to start on ORTEX.
Sign up for free →Open VKTX on ORTEX